Sclerotherapy and Bone Marrow Injection In Aneurysmal Bone Cyst

Aneurysmal bone cysts (ABCs) are benign, locally destructive growing bone tumors, which were first described in 1942 by Jaffé and Lichtenstein (1). They are most often diagnosed in childhood and early adulthood. The literature reports that ABCs comprise 1-6% of all primary benign bone tumors (2). Most cases of ABCs (75-90%) are reported for patients younger than 20 years, with a slightly higher incidence for females (3). Most common localizations are the pelvis, the metaphysis of long bones and the spine, but ABCs can also affect any other localization(2). ABCs that are associated with a preexisting osseous lesion are defined as secondary ABCs. They represent approximately 30% of all ABCs (2). Secondary ABCs can occur, e.g., in cases of a giant cell tumor, chondroblastoma or telangiectatic osteosarcoma

Inclusion Criteria:All Patients above age of 1 year.The affected area was all bones except skull, ribs, and other non-orthopedic specialties.Primary or recurrent ABCIncomplete Fractured affected bones as greenstick fracture.Healed Pathological fracture without any surgical interventionExclusion Criteria:ABC. In skull, ribs, and other non-orthopedic specialties.Age less than 1 yearSuspected malignancy or other bone cystsComplete fractured bones and healed pathological fracture with surgical intervention.